|  | 
| MechanismRIPK1 inhibitors | 
|  | 
|  | 
|  | 
|  | 
| Drug Highest PhasePreclinical | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
|  | 
|  | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhasePreclinical | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
| Target- | 
| Mechanism- | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseDiscovery | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
100 Clinical Results associated with BiSiChem Co. Ltd.
0  Patents (Medical) associated with BiSiChem Co. Ltd.
100 Deals associated with BiSiChem Co. Ltd.
100 Translational Medicine associated with BiSiChem Co. Ltd.